• Home
  1. Home
  2. Window of opportunity for developing effective medical intervention for calcific aortic valve disease
Scientific article
Editorial
OA Policy
English

Window of opportunity for developing effective medical intervention for calcific aortic valve disease

ContributorsMach, Françoisorcid; Miteva, Kapka Todorovaorcid
Published inEuropean heart journal, vol. 45, no. 37, p. 3886-3888
Publication date2024-10-05
Abstract

Refers to : Huang Y, Wang C, Zhou T, Xie F, Liu Z, Xu H, Liu M, Wang S, Li L, Chi Q, Shi J, Dong N, Xu K. Lumican promotes calcific aortic valve disease through H3 histone lactylation. Eur Heart J. 2024 Oct 5;45(37):3871-3885. doi: 10.1093/eurheartj/ehae407. PMID: 38976370.

Keywords
  • Humans
  • Calcinosis / diagnostic imaging
  • Aortic Valve / surgery
  • Aortic Valve / diagnostic imaging
  • Aortic Valve / pathology
  • Aortic Valve Stenosis / surgery
  • Aortic Valve Disease / surgery
Affiliation entities
Research groups
Citation (ISO format)
MACH, François, MITEVA, Kapka Todorova. Window of opportunity for developing effective medical intervention for calcific aortic valve disease. In: European heart journal, 2024, vol. 45, n° 37, p. 3886–3888. doi: 10.1093/eurheartj/ehae426
Main files (1)
Article (Published version)
accessLevelPublic OA OTHER
Identifiers
Additional URL for this publicationhttps://academic.oup.com/eurheartj/article/45/37/3886/7731674
Journal ISSN0195-668X
23views
44downloads

Technical informations

Creation01/10/2025 10:48:36
First validation04/12/2025 08:43:47
Update04/12/2025 08:45:54
Status update04/12/2025 08:45:54
Last indexation04/12/2025 08:45:55
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack